Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol
Authors
Keywords
-
Journal
Journal of Clinical Hypertension
Volume 22, Issue 10, Pages 1780-1788
Publisher
Wiley
Online
2020-09-17
DOI
10.1111/jch.14011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations
- (2020) Thomas C Hanff et al. CLINICAL INFECTIOUS DISEASES
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
- (2020) James H Diaz JOURNAL OF TRAVEL MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
- (2020) Christopher M Petrilli et al. BMJ-British Medical Journal
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Response by Cohen et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”
- (2020) Jordana B. Cohen et al. CIRCULATION RESEARCH
- Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
- (2020) Jan Wysocki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
- (2018) Jay Ramchand et al. PLoS One
- Safety of Temporary Discontinuation of Antihypertensive Medication in Patients With Difficult-to-Control HypertensionNovelty and Significance
- (2017) Martine M.A. Beeftink et al. HYPERTENSION
- Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure
- (2017) Christopher M. O’Connor et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation
- (2016) Meera N. Harhay et al. PLoS One
- Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial
- (2015) F Perry Wilson et al. LANCET
- A trial of in-hospital, electronic alerts for acute kidney injury: Design and rationale
- (2014) Francis Perry Wilson et al. Clinical Trials
- Roles of Coagulation and Fibrinolysis in Angiotensin II-Enhanced Microvascular Thrombosis
- (2014) Elena Y. Senchenkova et al. MICROCIRCULATION
- Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension
- (2012) Qiuping Gu et al. CIRCULATION
- Combination renin–angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions
- (2012) Luke J. Burchill et al. CLINICAL SCIENCE
- Section 2: AKI Definition
- (2012) Kidney International Supplements
- A Global Rank End Point for Clinical Trials in Acute Heart Failure
- (2010) G. Michael Felker et al. Circulation-Heart Failure
- A Modified Sequential Organ Failure Assessment Score for Critical Care Triage
- (2010) Colin K. Grissom et al. Disaster Medicine and Public Health Preparedness
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started